Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:focus |
development of novel therapies for infectious diseases
|
| gptkbp:founded |
2016
|
| gptkbp:headquartersLocation |
gptkb:United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Artemisone
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockSymbol |
gptkb:ATMS
|
| gptkbp:therapeuticArea |
gptkb:cytomegalovirus_infection
malaria |
| gptkbp:website |
http://www.artemis-therapeutics.com/
|
| gptkbp:bfsParent |
gptkb:ARTM
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Artemis Therapeutics Inc.
|